Chinese General Practice ›› 2024, Vol. 27 ›› Issue (14): 1699-1707.DOI: 10.12114/j.issn.1007-9572.2023.0397
• Article • Previous Articles Next Articles
Received:
2023-06-17
Revised:
2023-10-16
Published:
2024-05-15
Online:
2024-03-22
Contact:
REN Shouan
通讯作者:
任寿安
作者简介:
作者贡献:
王剑英、任寿安负责研究方案的提出与设计;王剑英负责进行调查对象的选取、数据采集、数据的分析、统计学分析、绘制图表、论文起草;任寿安负责最终版本修订,对论文负责。
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0397
项目 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | χ2(F)值 | P值 |
---|---|---|---|---|---|
性别(男/女) | 43/13 | 40/22 | 143/35 | 8.382 | 0.021 |
年龄(岁) | 49.5±14.7 | 53.9±15.3 | 47.6±12.4 | 4.967a | 0.008 |
BMI(kg/m2) | 26.2±3.4 | 27.4±3.5 | 30.0±5.0 | 19.403a | <0.001 |
颈围(cm) | 37.14±3.58 | 37.86±3.31 | 40.48±3.40 | 27.254a | <0.001 |
日间嗜睡[例(%)] | 28(50.0) | 38(61.3) | 114(64.0) | 13.020 | 0.001 |
高血压史[例(%)] | 10(17.9) | 54(87.1) | 155(87.1) | 7.929 | 0.036 |
糖尿病史[例(%)] | 22(39.3) | 33(53.2) | 99(55.6) | 6.450 | 0.049 |
Table 1 Comparison of general data among the three groups
项目 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | χ2(F)值 | P值 |
---|---|---|---|---|---|
性别(男/女) | 43/13 | 40/22 | 143/35 | 8.382 | 0.021 |
年龄(岁) | 49.5±14.7 | 53.9±15.3 | 47.6±12.4 | 4.967a | 0.008 |
BMI(kg/m2) | 26.2±3.4 | 27.4±3.5 | 30.0±5.0 | 19.403a | <0.001 |
颈围(cm) | 37.14±3.58 | 37.86±3.31 | 40.48±3.40 | 27.254a | <0.001 |
日间嗜睡[例(%)] | 28(50.0) | 38(61.3) | 114(64.0) | 13.020 | 0.001 |
高血压史[例(%)] | 10(17.9) | 54(87.1) | 155(87.1) | 7.929 | 0.036 |
糖尿病史[例(%)] | 22(39.3) | 33(53.2) | 99(55.6) | 6.450 | 0.049 |
血氧指标 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | H值 | P值 |
---|---|---|---|---|---|
LSpO2(%) | 86(84,89) | 82(77,86)a | 73(62,78)ab | 123.04 | <0.001 |
MSpO2(%) | 94(93,95) | 93(92,94) | 92(88,93)ab | 81.84 | <0.001 |
BSpO2(%) | 94(93,95) | 94(93,95) | 94(93,95) | 9.30 | 0.791 |
ODI(次/h) | 9.95(7.75,12.83) | 23.10(19.40,26.80)a | 58.00(41.68,73.68)ab | 201.68 | <0.001 |
T90(%) | 0.35(0,1.85) | 3.15(0.80,7.80)a | 19.30(9.48,55.15)ab | 117.66 | <0.001 |
Table 2 Comparison of blood oxygen indexes among the three groups
血氧指标 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | H值 | P值 |
---|---|---|---|---|---|
LSpO2(%) | 86(84,89) | 82(77,86)a | 73(62,78)ab | 123.04 | <0.001 |
MSpO2(%) | 94(93,95) | 93(92,94) | 92(88,93)ab | 81.84 | <0.001 |
BSpO2(%) | 94(93,95) | 94(93,95) | 94(93,95) | 9.30 | 0.791 |
ODI(次/h) | 9.95(7.75,12.83) | 23.10(19.40,26.80)a | 58.00(41.68,73.68)ab | 201.68 | <0.001 |
T90(%) | 0.35(0,1.85) | 3.15(0.80,7.80)a | 19.30(9.48,55.15)ab | 117.66 | <0.001 |
呼吸事件持续时间参数 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | H值 | P值 |
---|---|---|---|---|---|
MTAD(s) | 19.50(17.10,22.20) | 21.95(18.78,25.75)a | 25.95(22.08,30.83)ab | 58.360 | <0.001 |
MHD(s) | 34.30(32.38,39.55) | 35.05(29.85,39.48) | 30.15(26.10,36.60)ab | 20.532 | <0.001 |
MAD(s) | 29.58(25.74,32.90) | 29.87(24.36,33.42) | 27.81(24.65,32.08) | 3.368 | 0.186 |
LTAD(s) | 38.00(29.50,50.50) | 52.00(39.00,71.25)a | 72.00(57.75,89.25)ab | 84.699 | <0.001 |
LHD(s) | 88.50(62.50,101.25) | 93.00(72.00,110.00) | 79.50(49.75,105.00)b | 7.779 | 0.020 |
LAD(s) | 88.50(65.50,101.25) | 93.50(74.75,113.75) | 93.50(77.00,114.25)a | 7.575 | 0.023 |
TAD(min) | 33.25(25.79,47.77) | 83.19(70.41,97.09)a | 218.97(157.04,291.33)ab | 207.318 | <0.001 |
AHT%(%) | 6.88(5.35,10.16) | 16.80(14.42,19.81)a | 42.66(32.35,58.47)ab | 208.223 | <0.001 |
Table 3 Comparison of respiratory event duration parameters among the three groups
呼吸事件持续时间参数 | 轻度OSA组(n=56) | 中度OSA组(n=62) | 重度OSA组(n=178) | H值 | P值 |
---|---|---|---|---|---|
MTAD(s) | 19.50(17.10,22.20) | 21.95(18.78,25.75)a | 25.95(22.08,30.83)ab | 58.360 | <0.001 |
MHD(s) | 34.30(32.38,39.55) | 35.05(29.85,39.48) | 30.15(26.10,36.60)ab | 20.532 | <0.001 |
MAD(s) | 29.58(25.74,32.90) | 29.87(24.36,33.42) | 27.81(24.65,32.08) | 3.368 | 0.186 |
LTAD(s) | 38.00(29.50,50.50) | 52.00(39.00,71.25)a | 72.00(57.75,89.25)ab | 84.699 | <0.001 |
LHD(s) | 88.50(62.50,101.25) | 93.00(72.00,110.00) | 79.50(49.75,105.00)b | 7.779 | 0.020 |
LAD(s) | 88.50(65.50,101.25) | 93.50(74.75,113.75) | 93.50(77.00,114.25)a | 7.575 | 0.023 |
TAD(min) | 33.25(25.79,47.77) | 83.19(70.41,97.09)a | 218.97(157.04,291.33)ab | 207.318 | <0.001 |
AHT%(%) | 6.88(5.35,10.16) | 16.80(14.42,19.81)a | 42.66(32.35,58.47)ab | 208.223 | <0.001 |
指标 | LSpO2 | MSpO2 | BSpO2 | ODI | T90 |
---|---|---|---|---|---|
AHI | -0.698a | -0.578a | 0.032 | 0.975a | 0.645a |
MTAD | -0.506a | -0.369a | 0.092 | 0.339a | 0.436a |
MHD | 0.290a | 0.239a | -0.032 | -0.410a | -0.269a |
MAD | -0.064 | -0.072 | 0.057 | -0.181a | 0.064 |
LTAD | -0.590a | -0.402a | 0.039 | 0.385a | 0.445a |
LHD | 0.293a | 0.299a | -0.031 | -0.317a | -0.349a |
LAD | -0.151a | -0.045 | -0.010 | -0.046 | 0.022 |
TAD | -0.734a | -0.606a | 0.052 | 0.886a | 0.671a |
AHT% | -0.733a | -0.607a | 0.076 | 0.908a | 0.676a |
Table 4 Correlation analysis between duration parameters of respiratory events and blood oxygen indexes in OSA patients
指标 | LSpO2 | MSpO2 | BSpO2 | ODI | T90 |
---|---|---|---|---|---|
AHI | -0.698a | -0.578a | 0.032 | 0.975a | 0.645a |
MTAD | -0.506a | -0.369a | 0.092 | 0.339a | 0.436a |
MHD | 0.290a | 0.239a | -0.032 | -0.410a | -0.269a |
MAD | -0.064 | -0.072 | 0.057 | -0.181a | 0.064 |
LTAD | -0.590a | -0.402a | 0.039 | 0.385a | 0.445a |
LHD | 0.293a | 0.299a | -0.031 | -0.317a | -0.349a |
LAD | -0.151a | -0.045 | -0.010 | -0.046 | 0.022 |
TAD | -0.734a | -0.606a | 0.052 | 0.886a | 0.671a |
AHT% | -0.733a | -0.607a | 0.076 | 0.908a | 0.676a |
分组 | 亚组 | LSpO2 | MSpO2 | BSpO2 | ODI | T90 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | rs值 | P值 | rs值 | P值 | ||
短事件组 | 短TAD亚组(n=74) | ||||||||||
TAD | -0.377 | <0.010 | -0.188 | 0.109 | -0.140 | 0.233 | 0.528 | <0.010 | 0.107 | 0.363 | |
AHI | -0.471 | <0.010 | -0.250 | 0.032 | -0.186 | 0.113 | 0.766 | <0.010 | 0.215 | 0.066 | |
短AHT%亚组(n=74) | |||||||||||
AHT% | -0.360 | <0.010 | -0.216 | 0.065 | -0.138 | 0.241 | 0.570 | <0.010 | 0.102 | 0.386 | |
AHI | -0.487 | <0.010 | -0.274 | 0.018 | -0.206 | 0.078 | 0.741 | <0.010 | 0.244 | 0.036 | |
长事件组 | 长TAD亚组(n=222) | ||||||||||
TAD | -0.642 | <0.010 | -0.584 | <0.010 | 0.046 | 0.497 | 0.806 | <0.010 | 0.690 | <0.010 | |
AHI | -0.584 | <0.010 | -0.539 | <0.010 | 0.019 | 0.778 | 0.962 | <0.010 | 0.643 | <0.010 | |
长AHT%亚组(n=222) | |||||||||||
AHT% | -0.640 | <0.010 | -0.589 | <0.010 | 0.078 | 0.247 | 0.841 | <0.010 | 0.705 | <0.010 | |
AHI | -0.583 | <0.010 | -0.540 | <0.010 | 0.019 | 0.778 | 0.962 | <0.010 | 0.645 | <0.010 |
Table 5 Correlation analysis of TAD,AHT% and AHI with blood oxygen indexes in the short event group and long event group
分组 | 亚组 | LSpO2 | MSpO2 | BSpO2 | ODI | T90 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | rs值 | P值 | rs值 | P值 | ||
短事件组 | 短TAD亚组(n=74) | ||||||||||
TAD | -0.377 | <0.010 | -0.188 | 0.109 | -0.140 | 0.233 | 0.528 | <0.010 | 0.107 | 0.363 | |
AHI | -0.471 | <0.010 | -0.250 | 0.032 | -0.186 | 0.113 | 0.766 | <0.010 | 0.215 | 0.066 | |
短AHT%亚组(n=74) | |||||||||||
AHT% | -0.360 | <0.010 | -0.216 | 0.065 | -0.138 | 0.241 | 0.570 | <0.010 | 0.102 | 0.386 | |
AHI | -0.487 | <0.010 | -0.274 | 0.018 | -0.206 | 0.078 | 0.741 | <0.010 | 0.244 | 0.036 | |
长事件组 | 长TAD亚组(n=222) | ||||||||||
TAD | -0.642 | <0.010 | -0.584 | <0.010 | 0.046 | 0.497 | 0.806 | <0.010 | 0.690 | <0.010 | |
AHI | -0.584 | <0.010 | -0.539 | <0.010 | 0.019 | 0.778 | 0.962 | <0.010 | 0.643 | <0.010 | |
长AHT%亚组(n=222) | |||||||||||
AHT% | -0.640 | <0.010 | -0.589 | <0.010 | 0.078 | 0.247 | 0.841 | <0.010 | 0.705 | <0.010 | |
AHI | -0.583 | <0.010 | -0.540 | <0.010 | 0.019 | 0.778 | 0.962 | <0.010 | 0.645 | <0.010 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events Summary of Updates in Version 2.6[EB/OL]. [2023-05-20].
|
[9] |
|
[10] |
|
[11] |
|
[12] |
马长秀. 呼吸暂停低通气持续时间在阻塞性睡眠呼吸暂停症状及严重程度评价中的意义[D]. 合肥:安徽医科大学,2021.
|
[13] |
中华医学会呼吸病学分会睡眠呼吸疾病学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志,2012,35(1):9-12.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
丁秀,张俊波,边秋丽,等. 脉搏血氧饱和度监测在诊断阻塞性睡眠呼吸暂停综合征严重程度中的价值[J]. 中华医学杂志,2014,94(48):3801-3804. DOI:10.3760/cma.j.issn.0376-2491.2014.48.003.
|
[1] | HUANG Dan, ZHANG Qihan, SONG Ge, WANG Qing, LI Yu, JI Xunming, WANG Yuan. Efficacy and Safety of Intermittent Hypoxic Training in the Prevention of Acute Hypoxic Injury [J]. Chinese General Practice, 2023, 26(29): 3640-3644. |
[2] | WANG Jingyu, HONG Shenda, HAN Fang, LIU Guoli. A Review of Recent Advances in Screening for Obstructive Sleep Apnea during Pregnancy [J]. Chinese General Practice, 2023, 26(20): 2555-2558. |
[3] | DING Qidi, CAO Zhaolong, HAN Fang. Advances in the Diagnosis and Treatment of Sleep-disordered Breathing in Neuromuscular Disease [J]. Chinese General Practice, 2022, 25(33): 4203-4206. |
[4] | ZHANG Wei, CHANG Yuan, FENG Junjun, HAN Fang. Diagnostic Significance of Suggested Immobilization Test in Restless Leg Syndrome [J]. Chinese General Practice, 2022, 25(33): 4168-4172. |
[5] | Ruiling LIANG, Chenyang LI, Rui ZHAO, Bing ZHOU, Xiaosong DONG, Fang HAN. Screening Value of Smartphone App Snoring Analysis Software for Obstructive Sleep Apnea hypopnea Syndrome [J]. Chinese General Practice, 2022, 25(17): 2061-2066. |
[6] |
LIU Yanan, WANG Xi, ZHANG Cheng, SHEN Yane, MA Jing, WANG Guangfa.
Effects of Non-invasive Positive Pressure Ventilation on Sleep of Patients in Respiratory Intensive Care Unit Assessed by Overnight Polysomnography [J]. Chinese General Practice, 2022, 25(11): 1346-1350. |
[7] | CHENG Jie,WANG Qian,DONG Lihuan,WANG Weiliang. Effect of Tomatis Listening Therapy on Sleep Structure in Patients with Acute Cerebral Hemorrhage [J]. Chinese General Practice, 2019, 22(26): 3165-3170. |
[8] | MA Xiao,LU Ying,CHEN Qianhua. Epicardial Fat Thickness and Severity of Obstructive Sleep Apnea-hypopnea Syndrome in Obese and Nonobese Patients [J]. Chinese General Practice, 2019, 22(17): 2052-2057. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||